Characterization of human platelet binding of recombinant T cell receptor ligand

BACKGROUND: Recombinant T cell receptor ligands (RTLs) are bio-engineered molecules that may serve as novel therapeutic agents for the treatment of neuroinflammatory conditions such as multiple sclerosis (MS). RTLs contain membrane distal α1 plus β1 domains of class II major histocompatibility compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Itakura, Asako, Aslan, Joseph E, Sinha, Sushmita, White-Adams, Tara C, Patel, Ishan A, Meza-Romero, Roberto, Vandenbark, Arthur A, Burrows, Gregory G, Offner, Halina, McCarty, Owen JT
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992052/
https://www.ncbi.nlm.nih.gov/pubmed/21059245
http://dx.doi.org/10.1186/1742-2094-7-75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992052/
https://www.ncbi.nlm.nih.gov/pubmed/21059245
http://dx.doi.org/10.1186/1742-2094-7-75

Ejemplares similares